In this paper, we conclude that CAV-1 plays a crucial role in inhibiting CypA-mediated ROS production, improving dyslipidemia, maintaining mitochondrial function, and attenuating oxidative stress responses that are vital for cell survival in hypercholesterol-affected renal organs. This evidence concerns the gene CAV1 and metabolic syndrome.